Product logins

Find logins to all Clarivate products below.


Heart Valve Devices – Market Insights – Japan

The Japanese heart valve device market will experience modest growth, primarily driven by the increasing adoption of THV devices. Positive clinical outcomes and the introduction of innovative products will expand the eligible patient pool, fueling sustained growth in the heart valve device market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Japan from 2019 through 2033.

Transcatheter replacement therapies will be the driving the Japanese heart valve replacement device market.

Which new TAVI devices are poised to enter the market? What impact will these newer devices have on market dynamics and market growth?

What new transcatheter replacement devices have been approved in the Japanese market? How will they impact the overall heart valve device market?

When is TMVI therapy expected to enter the Japanese market? What TMVI devices are in development?

How will MHLW reimbursement affect TAVI adoption?

How the growth in the THV device market is going to impact the surgical market?

The competitive landscape for the THV device market is evolving.

Which competitors have the most diverse portfolios in the heart valve device space?

How companies are gaining a competitive edge through mergers and acquisitions?

MHLW reimbursement revisions will affect the Japanese heart valve device market.

How has Japan’s regulatory framework changed to align with global regulatory requirements?

What is the impact of Japan’s regulatory approval process on product launches in Japan?

What other factors will affect ASP trends?

Clinical trial results play an important factor in the heart valve device market.

How are clinical studies and guidelines impacting the uptake of THV devices?

What segments have been the most impacted by clinical results?

What will be the market impact of the approval of expanded indications for TAVI?

What technologies are larger players focusing on, and how will the first-mover advantage benefit these competitors?

Table of contents


Related Medtech Insights Reports

Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow moderately through the forecast period, driven by rising procedure volumes, anticipated product launches, and increasing affordability of…
Report
Deep Venous Disease Treatment Devices – Market Insights – Global
The uptake of innovative, higher-priced powered thrombectomy devices and their increasing adoption for treating PE—supported by favorable clinical data—will drive strong growth in the global…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…